Patent application number | Description | Published |
20080249108 | Chemical Compounds - The invention relates to methods for the treatment of medical conditions comprising administering an effective amount of a compound of formula (I): | 10-09-2008 |
20080262041 | Beta-Lactams for Treatment of Cns Disorders - The present invention relates to novel compounds of formula (I): | 10-23-2008 |
20080269208 | Pyridine Derivatives and Their Use in the Treatment of Psychotic Disorders - There are provided according to the invention novel compounds of formula (I) or a pharmaceutically acceptable salt or solvate thereof: | 10-30-2008 |
20090221593 | TRIAZOLE DERIVATIVES AS MODULATORS OF DOPAMINE D3 RECEPTORS - The present invention relates to novel compounds of formula (I) or a salt thereof: | 09-03-2009 |
20090281135 | 3-AZABICYCLO [4. 1. 0] HEPTANE DERIVATIVES FOR THE TREATMENT OF DEPRESSION - The present invention relates to novel compounds of formula (I) or pharmaceutically acceptable salts, solvates or prodrugs thereof: | 11-12-2009 |
20100035914 | AZABICYCLIC COMPOUNDS AS INHIBITORS OF MONOAMINES REUPTAKE - The present invention relates to novel compounds of formula (I)′, and pharmaceutically acceptable salts, prodrugs or solvates thereof: | 02-11-2010 |
20100063078 | SPIROCOMPOUNDS USEFUL AS MODULATORS FOR DOPAMINE D3 RECEPTORS - The present invention relates to novel compounds of formula (I) or salts thereof: | 03-11-2010 |
20100069416 | Azabicyclo [3.1.0] Hexyl Derivatives as Modulators of Dopamine D3 Receptors - The present invention relates to certain azabicyclo compounds of formula (I)′: | 03-18-2010 |
20100081667 | Chemical Compounds - The present invention provides a method for the treatment of emesis in a mammal being treated with an opiod analgesic | 04-01-2010 |
20100144760 | NOVEL COMPOUNDS - Disclosed are N-{[(1R,4S,6R)-3-(2-pyridinylcarbonyl)-3-azabicyclo[4.1.0]hept-4-yl]methyl}-2-heteroarylamine derivatives and their use as pharmaceuticals. | 06-10-2010 |
20100152175 | Pyridine Derivatives and Their Use in The Treatment of Psychotic Disorders - There are provided according to the invention novel compounds of formula (I) or a pharmaceutically acceptable salt thereof: | 06-17-2010 |
20100152195 | Azabicyclo (3.1.0) Hexane Derivatives Useful As Modulators Of Dopamine D3 Receptors - The present invention relates to novel compounds of formula (I) or a pharmaceutically acceptable salt thereof: | 06-17-2010 |
20100152446 | Piperidine Derivatives - The present invention relates to piperidine derivatives of formula (I) | 06-17-2010 |
20100160336 | Azabicyclo (3.1.0) Hexane Derivatives Useful As Modulators Of Dopamine D3 Receptors - The present invention relates to novel compounds of formula (I) or a pharmaceutically acceptable salt thereof: | 06-24-2010 |
20100168131 | NOVEL COMPOUNDS - Disclosed are N-{[(1S,4S,6S)-3-(2-pyridinylcarbonyl)-3-azabicyclo [4.1.0]hept-4-yl]methyl}-2-heteroarylamine derivatives and their use as pharmaceuticals. | 07-01-2010 |
20100190764 | Novel compounds - This invention relates to novel Spiro cyclopentane derivatives of formula (I) or a pharmaceutically acceptable salt thereof, for treating diseases and conditions of the central nervous system (CNS), in particular sleep disorders. | 07-29-2010 |
20100286151 | 1-OXA-3-Azaspiro[4,5]Decan--2-One Derivatives For The Treatment Of Eating Disorders - The present invention relates to novel compounds of formula (I), or a pharmaceutically acceptable salt or solvate thereof, | 11-11-2010 |
20100286152 | N-PHENYL HYDRAZIDES AS MODULATORS OF THE GHRELIN RECEPTOR - The present invention relates to novel compounds of formula (I) or a pharmaceutically acceptable salt or solvate thereof, | 11-11-2010 |
20100311734 | Spiro Compounds Useful as Antagonists of the H1 Receptor - The invention provides a compound of formula (I) or a pharmaceutically acceptable salt thereof, for treating diseases and conditions of the central nervous system (CNS), in particular sleep disorders. | 12-09-2010 |
20110172255 | Condensed N-Heterocyclic Compounds and their Use as CRF Receptor Antagonists - The present invention provides compounds of formula (I), processes for their preparation, pharmaceutical compositions containing them and their use in the treatment of conditions mediated by corticotropin-releasing factor (CRF). | 07-14-2011 |
20120040991 | 3-AZABICYCLO [4.1.0] HEPTANES USED AS OREXIN ANTAGONISTS - Disclosed are 3-azabicyclo[4.1.0]heptane derivatives of formula (I) and their use as orexin receptor antagonists. | 02-16-2012 |
20120149711 | PIPERIDINE DERIVATIVES USED AS OREXIN ANTAGONISTS - This invention relates to heteroarylamine methyl substituted piperidine derivatives (I) and their use as antagonists of human orexin. | 06-14-2012 |
20120149723 | 5-METHYL-PIPERIDINE DERIVATIVES AS OREXIN RECEPTOR ANTAGONISTS FOR THE TREATMENT OF SLEEP DISORDER - This invention relates to heteroaryloxy 5-methyl substituted piperidine derivatives and their use as pharmaceuticals. | 06-14-2012 |
20150018345 | NOVEL NEUROKININ 1 RECEPTOR ANTAGONIST COMPOUNDS - The present invention relates to a compound according to formula (A) wherein n is 1 or 2; R1 and R2 are independently hydrogen, C | 01-15-2015 |